Exploring the effects of integrative health in cancer

September 24, 2018

New Rochelle, NY, September 24, 2018--A Special Focus Issue on Integrative Oncology takes a wide-ranging view of the possible approaches and potential therapeutic benefits of complementary and integrative medicine in multiple age groups, nations, and special populations. The Special Focus Issue is published in JACM, The Journal of Alternative and Complementary Medicine, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers, dedicated to paradigm, practice, and policy advancing integrative health. Click here to read the full-text articles free on the JACM website through October 24, 2018.

A series of fascinating and thought-provoking articles from North America, Europe, the Middle East, and Asia - 6 invited reviews, 13 original research articles, 7 commentaries, and 2 editorials - have been selected to appear in this Special Focus Issue by Guest Editors Moshe Frenkel, MD, University of Texas Medical Branch, Director of the Complementary and Integrative Medicine Unit at Meir Medical Center, Israel and Lynda Balneaves, PhD RN, President of the Society for Integrative Oncology and Associate Professor, Rady Faculty of Health Sciences, University of Manitoba, Canada.

Among the invited reviews is "Integrative Medicine in Childhood Cancer" by Elena Ladas, PhD, RD, Columbia University, New York City, NY, which examines the increasing use of integrative health measures among pediatric cancer patients, most often as supportive care agents. Dr. Ladas takes a close look at the options and effectiveness of nutritional and dietary strategies, including specialized diets and nutritional supplements such as probiotics. She also evaluates complementary therapies in pediatric oncology, including acupuncture, aromatherapy, and massage.

Erika Stoerkel, MPH, Thought Leadership and Innovation Foundation, McLean, VA and colleagues from University of Texas Health San Antonio, TX, Brooke Army Medical Center, Fort Sam Houston, TX, and Samueli Institute, Alexandria, VA, coauthored the article entitled "Effectiveness of a Self-Care Toolkit for Surgical Breast Cancer Patients in a Military Treatment Facility." The researchers compared two groups of women about to undergo surgery for breast cancer, one of which was given a self-care toolkit. The toolkit contained an MP3 player with audio-files to guide the user in guided breathing techniques, progressive muscle relaxation, meditation, guided imagery, and self-hypnosis. Data collected at various timepoints before and after surgery included measurements of anxiety, pain, nausea, sleep, fatigue, global health, quality of life, and two inflammatory blood markers. The results showed significant differences between the two groups

In his commentary intriguingly titled "Exceptional Responders, Outliers, and Radical Remissions," cancer survivor Glenn Sabin, of FON Therapeutics, Silver Spring, MD, and author of n of 1, an account of his personal journey, focuses on cancer patients who spontaneously go into remission--also called outliers or exceptional responders. Should these patients be studied or ignored? Dr. Sabin argues that they should be studied and explains why and how, targeting the patient-physician relationship and the potential role of a supportive environment.

"Guest editors Frenkel and Balneaves clearly struck a chord when they chose to engage this project, drawing nearly 70 submissions," says JACM Editor-in-Chief John Weeks, johnweeks-integrator.com, Seattle, WA. "As part of our ongoing interest in integrative oncology research, JACM is excited to contribute this Special Issue in the global community process of building an evidence road to guide and establish the integrative oncology model."
-end-
About the Journal

JACM, The Journal of Alternative and Complementary Medicine is a monthly peer-reviewed journal published online with open access options and in print that is dedicated to research on paradigm, practice, and policy advancing integrative health. Led by John Weeks (johnweeks-integrator.com), the co-founder and past Executive Director of the Academic Collaborative for Integrative Health, JACM publishes human clinical trials, observational studies, systematic reviews and commentary intended to help healthcare professionals, delivery organization leaders, policy-makers and scientists evaluate and integrate therapies into patient care protocols, payment strategies and appropriate protocols. Complete tables of content and a sample issue may be viewed on the JACM website.

About the Publisher

Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Alternative and Complementary Therapies, Medical Acupuncture, and Journal of Medicinal Food. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.

Mary Ann Liebert, Inc./Genetic Engineering News

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.